Bluefin Capital Management, LLC Abb Vie Inc. Transaction History

Bluefin Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $253,821 - $293,835	-1,900 Reduced 55.88%	1,500 $223,000
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $450,533 - $560,660	3,400 New	3,400 $458,000
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $258,639 - $310,176	-1,870 Reduced 18.32%	8,340 $1.35 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $193,262 - $221,659	-1,440 Reduced 12.36%	10,210 $1.37 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $604,151 - $768,074	4,390 Added 60.47%	11,650 $1.8 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $1.75 Million - $2.18 Million	-13,297 Reduced 64.68%	7,260 $1.18 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $1.31 Million - $1.66 Million	-12,235 Reduced 37.31%	20,557 $2.78 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $1.18 Million - $1.34 Million	11,134 Added 51.41%	32,792 $3.54 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $610,954 - $680,638	5,807 Added 36.63%	21,658 $2.44 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $360,914 - $397,323	3,528 Added 28.63%	15,851 $1.72 Million
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $1.08 Million - $1.45 Million	-13,389 Reduced 52.07%	12,323 $1.32 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $2.21 Million - $2.59 Million	25,712 New	25,712 $2.25 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bluefin Capital Management, LLC with notifications on news.